Evaluation and Management of Persistent Hot Sensation in a Patient on Antiseizure Medication and Escitalopram
This patient requires immediate evaluation for serotonin syndrome and drug-induced hyperthermia, with particular attention to the combination of escitalopram and antiseizure medications, as this represents a potentially life-threatening condition that demands urgent assessment of vital signs, mental status, neuromuscular findings, and core temperature.
Immediate Clinical Assessment Required
Critical Signs to Evaluate NOW:
- Core body temperature (not just subjective sensation)
- Mental status changes: agitation, confusion, delirium
- Neuromuscular examination:
- Muscle rigidity or hypertonicity
- Hyperreflexia (especially in lower extremities)
- Myoclonus or tremor
- Incoordination
- Autonomic instability:
- Tachycardia
- Blood pressure fluctuations
- Diaphoresis (excessive sweating)
- Flushing 1
Laboratory Workup:
- Creatine kinase (CK) - to assess for rhabdomyolysis
- Serum sodium - SSRIs commonly cause hyponatremia 1
- Complete metabolic panel
- Arterial blood gas if any systemic signs present
Primary Differential Diagnoses
1. Serotonin Syndrome (Most Concerning)
Escitalopram is an SSRI that can cause serotonin syndrome, particularly when combined with other serotonergic agents. The syndrome presents with:
- Mental status changes (agitation, confusion)
- Autonomic instability (tachycardia, labile BP, hyperthermia, diaphoresis)
- Neuromuscular hyperactivity (tremor, rigidity, myoclonus, hyperreflexia)
- GI symptoms (nausea, vomiting, diarrhea) 1
This is a medical emergency - if confirmed, immediately discontinue escitalopram and any other serotonergic agents, provide supportive care, and consider ICU admission 1.
2. Drug-Induced Hyperthermia from Antiseizure Medications
Antiepileptic drugs are significantly associated with hyperthermia presentations (p=0.03), particularly in patients on polypharmacy 2. The mechanism involves disruption of hypothalamic thermoregulation 3.
3. SSRI-Related Thermoregulatory Dysfunction
SSRIs can impair thermoregulation independent of serotonin syndrome. Escitalopram specifically lists hyperthermia as part of serotonin syndrome warning 1, but subclinical thermoregulatory effects may occur.
4. Hyponatremia-Related Symptoms
Escitalopram commonly causes SIADH, with cases of sodium <110 mmol/L reported. Symptoms include confusion, weakness, and potentially altered temperature perception 1.
Management Algorithm
Step 1: Rule Out Life-Threatening Syndromes
If ANY of the following are present, this is a medical emergency:
- Core temperature >38.5°C with neuromuscular findings
- Altered mental status
- Muscle rigidity
- Autonomic instability
- Elevated CK
Action: Discontinue escitalopram immediately, transfer to emergency department, initiate supportive care 1, 3.
Step 2: If Vital Signs Normal but Subjective Heat Sensation Persists
This may represent:
- Early/subclinical drug-induced thermoregulatory dysfunction - documented as an early warning sign even before objective hyperthermia develops 4
- SSRI side effect requiring dose adjustment or medication change
- Drug interaction between escitalopram and the specific antiseizure medication
Action:
- Check serum sodium level (hyponatremia common with escitalopram) 1
- Review complete medication list for serotonergic drug interactions
- Consider gradual escitalopram dose reduction or switch to alternative antidepressant with different mechanism
- Close monitoring for 2 weeks for emergence of objective findings
Step 3: Identify Specific Antiseizure Medication
Critical consideration: The specific antiseizure medication matters. Some antiepileptics have higher association with hyperthermia 2, and certain combinations with SSRIs may increase serotonin syndrome risk.
Key Drug Interaction Concerns
Escitalopram should NOT be combined with:
Use with caution when combined with:
- Tramadol, fentanyl, triptans, lithium, buspirone, St. John's Wort, amphetamines - all increase serotonin syndrome risk 1
Critical Pitfalls to Avoid
Do not dismiss subjective heat sensation as benign - this can be an early warning sign before objective hyperthermia develops 4
Do not attribute symptoms to "anxiety" without ruling out serotonin syndrome - the combination of SSRI + other medications creates real physiologic risk 1
Do not abruptly stop escitalopram without medical supervision - discontinuation syndrome includes dysphoria, dizziness, sensory disturbances, and can be severe 1
Do not overlook polypharmacy effects - elderly patients on multiple medications (antiepileptics + SSRIs + others) have significantly higher hyperthermia risk 2
Do not use antipyretics for drug-induced hyperthermia - they are ineffective because the mechanism is hypothalamic dysregulation, not inflammatory 3
Monitoring Plan
If continuing current medications:
- Weekly check-ins for first month
- Patient education on serotonin syndrome warning signs
- Avoid additional serotonergic agents
- Monitor sodium levels
- Reassess at any change in symptoms
If modifying treatment: